As Sonomax continues to liquidate inventory and work towards an R&D ------------------------------------------------------------------- licensing company, third Quarter 2009 highlights were: ------------------------------------------------------ - Reduction of operating expenses to $553,108 compared to $1,282,258 in 2008 - Raised $1,000,000 through private placement of 50,000,000 units consisting of one common share and one common share purchase warrant. - Decrease in revenue to $186,819 compared to $375,293 in 2008. - Gross profit was negative $191,848 in 2009 compared to $288,098 in 2008. - Reduction of operating expenses to $553,108 compared to $1,282,258 in 2008.
Full financial statements can be found at: www.sedar.com
About the New Sonomax:
Sonomax is an R&D and licensing company of in-ear technologies. The company's patented instant custom-fitting earpieces deliver the most comfortable sound enhancing earpieces in the world. This unique technology enables a wide range of applications such as earphones for the music and gaming markets, hearing protection for military and industrial applications, affordable hearing aids and the ever expanding Bluetooth(TM) headset market.
This news release contains certain forward-looking statements that reflect the current views and/or expectations of Sonomax Hearing Healthcare Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
%SEDAR: 00013736E
For further information: Nick Laperle, President, Sonomax Hearing Healthcare Inc., (514) 932-2674, [email protected]
Share this article